Nvidia CEO Jensen Huang hints at agentic AI at GTC; a Groq-based LPU could boost inference, defend its moat, and more. Click ...

The CBSE Class 12 Mathematics Board Examination 2026 was conducted today, on March 9, 2026. The tests were carried out between 10.30 am and 1.30 pm. Mathematics is best known as one of the most ...

CBSE 12th Accountancy Exam 2026 Highlights: The Class 12 Accountancy paper was held today from 10.30 am to 1.30 pm. Follow the blog for latest updates on exam analysis, students reactions and more.

CBSE Board Exams 2026 Highlights: The CBSE Class 12 Mathematics board examination began today, March 9 at 10:30 am and concluded at 1:30 pm. Students taking the exam will be able to find detailed ...

The Central Board of Secondary Education (CBSE) conducted Class 12 Maths, Applied Maths paper today, March 9. As per students, the Maths paper was analysed as "moderately difficult". According to Alka ...

ISC Class 12th Question Papers 2026: The ISC Class 12 examinations 2026 are conducting from 12th February to 6th April 2026 as per the schedule of the Council for the Indian School Certificate ...

Clone the LiteWing Library repository from GitHub using the following command: ...

Your weekly cybersecurity roundup covering the latest threats, exploits, vulnerabilities, and security news you need to know.

If you haven't done it before, changing your IP address may sound like something you need an advanced computer science degree for. But you can easily change your IP address with a VPN and other ...

TIOBE Index for March 2026: Top 10 Most Popular Programming Languages Your email has been sent Python keeps the top spot as its rating dips again, C climbs further in second, and the bottom stays ...

Apple is working on a 12th-generation iPad, and plans to update the most affordable tablet in the ‌iPad‌ lineup sometime this year. It's not going to be a major update, but if you're planning a ...

On day one of IPWatchdog LIVE 2026, panelists discussed the global IP landscape, the economics of patent portfolios, patent dealmaking and the ins and outs of drug patent critiques, before U.S. Court ...